Navigation Links
California Company Creates Medical Device That Could Change the Course of Medicine as We Know It
Date:12/18/2013

LOS ANGELES, Dec. 18, 2013 /PRNewswire/ -- Alsa Refinish LLC, a California-based company, has process and utility patent applications in place for a revolutionary medication delivery method.

If successful, Alsa will hold patents for a device that delivers medications and herbal preparations directly into the lungs through vaporization, or "vaping." It incorporates technology used in vaporizing pens and e-cigarettes, and in addition, adds Alsa's proprietary stationary mouth tube design. Alsa's innovative vaporization technology advances have created devices that can precisely measure and deliver medication.

"Vaping the drug would deliver it directly to the smallest areas of the lungs via harmless vapor," explains Ike Banoun, Alsa Refinish LLC president. "Our patents cover vaporizing a wide array of drugs and herbal therapies. The hypodermic needle is 400 years old. It's time it came into the non-invasive electronic world. I bet it will be in the museums of the future."

Alsa's device could vaporize many pharmaceutical drugs, NSAIDs, herbal supplements and vitamins. Good pharmaceutical candidates for vaporization include, but are not restricted to, nitroglycerin, sildenafil (Viagra), antibiotics and active ingredients of cough syrups. Patients that have asthma or cystic fibrosis could replace their inhalers with vaping devices to disinfect and treat the mucus with mucolytics in their lungs. Additionally, diabetic patients could also be delivered insulin via non-parenteral routes instead of taking painful injections.

The drug classes listed on Alsa's patent applications include antipyretic medications for fever reduction; NSAIDs to relieve pain, swelling and inflammation; and both opioid and non-opioid analgesics for pain relief. Heat-stable medications from any of these classes could potentially be administered through vaporization. Readily available treatments like Vicks Vaporub (active ingredients) could be delivered directly into the lungs instead of being smeared on the chest. Also, patients could use vaping devices to inhale therapeutic herbs in liquid form.

In addition to delivering medication through the mouth, vaporization can be used to administer medication nasally. This method of delivering medication doesn't pass through the stomach and liver, so it prevents loss of potency. In this way, vaping devices have the potential to treat diseases more easily and quickly, and to deliver analgesics for more effective pain management. Medications can also be flavored for making them palatable and for ease in administering to children.

Alsa envisions its vaping device as an effective and low-cost vaccine delivery solution for not-for-profit groups and healthcare providers. They could vaccinate the entire village with a single vaporization device, and inexpensive disposable tips to eliminate cross-contamination.  In fact, Alsa hopes to partner with the Gates Foundation to increase worldwide vaccine acceptance, availability and delivery.

Vaporization pens and e-cigarettes have widespread consumer appeal. These patents could present profitable financial opportunities for both investors and strategic partners. Interested parties can contact Alsa Refinish LLC to discuss possible joint ventures and investments. Alsa Refinish LLC has doctors on staff that are available to answer your questions.

About Alsa Refinish LLC: Alsa Refinish LLC's team of talented chemists and pharmaceutical experts are specialists in innovative research and development. Over its 20-year history, the company has partnered with companies like GE to deliver high-quality products and services.

Contact name: Ike Banoun
Email address: ike@alsa-refinish.com
Telephone number: 323-581-5200
Company street address: 1213 East 58th Place, Los Angeles, CA 90001
Company websites: TheV-Meds.com - Alsacorp.com


'/>"/>
SOURCE Alsa Refinish LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
2. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
3. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
4. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
5. Medbox, Inc. Comments on California Supreme Court Decision
6. Consumer Watchdog Calls For Political Response To Physician Drug Abuse Scandal, Including Mandatory Drug Testing for High Risk Doctors Across California
7. Comprehensive Care Corporation Announces New Medicare Contract with Humana Health Plan of California, Inc.
8. Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
9. Defective Medicare Bidding Program For Medical Equipment Forces Severe Hardships On California Business Owners And Beneficiaries
10. Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada
11. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):